14 天前 - … Immune checkpoint therapies (ICT) improve overall survival of patients with cancer
but may cause immune-related adverse events (irAEs) such as myocarditis. Cytotoxic T …

14 天前 - … tissue injuries known as immune-related adverse events (irAEs) [6, 7]. … of patients
and represent a significant adverse event associated with ICIs. Notably, about 10% of patients …

15 天前 - … treat‑ ment, but the occurrence of immune‑related adverse events induced by immune
checkpoint inhibitors (ICIs… and biomarkers for immune‑related adverse events: A practical …

15 天前 - … The efficacy of immune checkpoint inhibitors (ICIs) has been widely recognized for
… of patients who experience adverse events that prevent them from continuing treatment [5, 6]…

15 天前 - … inhibitors, how to manage? Eur J Cancer. 2019;122:72―90. … Management of
immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: …

16 天前 - … that patients who experience immune-related adverse events (irAE) as a result
of immunotherapy treatment, exhibit significantly improved outcomes compared to patients …

16 天前 - … a case of immune-related colitis in a patient with hepatocellular carcinoma who was
treated with an immune checkpoint inhibitor (ICI). Although immune-related adverse events …

16 天前 - … the development and clinical utility of immune checkpoint inhibitors (ICIs) for oncology,
… of ICIs as monotherapy is dominated by immune-related adverse events, which can be …

16 天前 - … an immune checkpoint inhibitor clinically used to treat various … reactions among
immune-related adverse reactions, great importance should be given to anaphylactic reactions …

18 天前 - … conducted in that area, especially on immune checkpoint inhibitors (ICIs), to help
fine-… and treating immune-related adverse events early on), and co-medication management …